European Urological Devices Procedure Numbers Report 2016: Increasing Global Awareness of Infection Rates is Helping to Drive a Single-Use Device Preference - Research and Markets
DUBLIN, October 10, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "European Procedure Numbers for Urological Devices 2016 - MedPro" report to their offering.
The European urology market includes the segments for TURP devices, laser BPH devices, brachytherapy, urinary catheters, nephrostomy devices, urinary incontinence slings, stone treatment devices, urological endoscopes and erectile dysfunction devices. As a whole the urological device market is very well established.
Although a highly commoditized market, an increasing global awareness of infection rates is helping to drive a single-use device preference. This results in higher unit sales and an associated growth in market value. Despite this preference, there is an ongoing push within the U.K. to gain acceptance of reusable catheters.
The shift within urological endoscopes from fiber devices to video devices is not complete and therefore the urological endoscope market should continue to exhibit strong growth for the near future. Additionally, the urinary catheter market is expected to exhibit strong growth, particularly hydrophilic catheters.
This limits potential for substantial growth. Although companies continue to provide novel adaptations to their products, the general trend within the market is a slightly declining ASP. However, some segments are an exception to this - lasers (for both BPH and stone management) have recently seen some exciting developments.
Key Topics Covered:
1. Executive Summary
2. Disease Overview
2.1 Basic Anatomy
2.1.1 Human Urinary System
2.2 Urinary Pathology And Disorders
2.2.1 Benign Prostate Hyperplasia
2.2.2 Urinary Incontinence
2.2.3 Urinary Tract Infections
2.2.4 Kidney Stones
2.2.5 Bladder Prolapse
2.2.6 Overactive Bladder
2.2.7 Prostatitis
2.2.8 Erectile Dysfunction (Ed)
2.2.9 Cancer
2.3 Patient Demographics
2.3.1 Benign Prostatic Hyperplasia
2.3.2 Urinary Incontinence
2.3.3 Uti
2.3.4 Kidney Stones
2.3.5 Erectile Dysfunction
2.3.6 Overactive Bladder
2.3.7 Prostatitis
2.3.8 Cancer
3. Country Profiles
3.1 Introduction
3.1.1.1 Population
3.1.1.2 Median Age
3.1.1.3 GDP Per Capita
3.1.1.4 Price Index
4. Procedure Numbers
4.1 Procedure Overview
4.2 Prostate Cancer Treatment Procedures
4.3 Interventional Bph Procedures
4.4 Stone Management Procedures
4.5 Nephrostomy Procedures
4.6 Urinary Incontinence Procedures
4.7 Erectile Dysfunction Management Procedures
Companies Mentioned
- Ace Medical Devices
- Ackermann
- Advanced Shockwave Technology
- Agency for Medical Innovations (A.M.I.)
- Allium Medical
- Amecath
- Apexmed International
- B. Braun
- BioDerm
- Biolitec
- Boston Scientific
- C. R. Bard
- CL Medical
- Caldera Medical
- Coloplast
- Convatec
- Convergent Laser Technologies
- Cook Medical
- Cousin Biotech
- Covidien
- Cure Medical
- Direx
- GE Healthcare (Oncura)
- Helioscopie
- Hollister
- IsoAid
- Karl Storz
- Olympus
- Richard Wolf
- Siemens
- Sopro-Comeg
- Stahl Endoscopy
- Stryker
- Wellspect Healthcare
- Zephyr Surgical Implants
For more information about this report visit http://www.researchandmarkets.com/research/cfprmm/european
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article